Health Fitness

Laghu Udyog Bharati (LUB), an association of small businesses which is an affiliate of the Rashtriya Swayamsevak Sangh (RSS), has…

The drug regulatory authority said unused and expired opioid drugs and painkillers at homes should be mandatorily discarded to prevent…

Drug maker Lupin on Monday said it has entered into a licence and supply agreement with SteinCares for commercialisation of…

India will soon come up with a structured framework for critical care to address the infrastructure and human resource gap…

In a first-of-its-kind pricing strategy in the pharmaceutical industry, Swiss drug major Novartis has introduced a financing scheme for its…

Mumbai: Quadria Capital, an Asia healthcare-focused private equity firm, has raised $1.07 billion for its third fund, exceeding its original…

BENGALURU/MUMBAI: A decade ago, India’s health supplements mostly meant vitamin C, iron and B12 tablets purchased at pharmacies after consulting…

Dr Reddy’s Laboratories has received Form 483 with two observations after the US health regulator inspected its API manufacturing plant…

In view of the recent increase in Covid-19 cases, the Delhi government Friday issued an advisory, asking hospitals to prepare…

When the world sneezes from a US-China chill, Indian companies rush to make medicines. Literally. Sometime in April, Vivek Sharma,…

Pharma major Venus Remedies on Saturday said it has successfully renewed its good manufacturing practices (GMP) certification from Ukraine’s State…

Sun Pharmaceutical Industries Ltd on Friday said it has entered into an agreement with US-based Pharmazz Inc to invest up…

Zydus Lifesciences is working on a differentiated single device that can be calibrated for use of semaglutide in multiple strengths,…

Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III clinical trials. The…

New Delhi: Many pharmaceutical companies in the micro, small and medium enterprise (MSME) sector are manufacturing substandard drugs, according to…

Neuberg Diagnostics, a leading diagnostic service provider, formed a joint venture with Maharashtra-based Star Imaging, a leader in advanced medical…

Malaysia’s IHH Healthcare has increased its damages claim by a tenfold to approximately Rs 11,800 crore from Japan’s Daiichi Sankyo…

Aman Mehta, third generation of Torrent Group’s founder Mehta family, was on Tuesday appointed Managing Director of the conglomerate’s flagship…

Aman Mehta, third generation of Torrent Group’s founder Mehta family, was on Tuesday appointed Managing Director of the conglomerate’s flagship…

Leading Indian drugmakers such as Eris Lifesciences, Lupin, Mankind and Wockhardt are making strong inroads into the country’s insulin market-long…

India’s orthopaedic and cardiac implant sector is expected to reach USD 4.5-5 billion by 2027-28, mainly driven by strong domestic…

Piramal Pharma has no plans to enter domestic prescription formulations business for now, chairperson Nandini Piramal told ET, putting to…

The U.S. Food and Drug Administration said on Friday it had cleared Fujirebio Diagnostics’ blood test to diagnose Alzheimer’s disease,…

Dr Reddy’s Laboratories on Saturday said the US health regulator has issued a Form 483 with two observations after inspecting…

As a professional from the pharmaceutical industry, Diogo Rau, the global chief information and technology officer at Eli Lilly, is…

New Delhi: Personal care products containing aloe vera, jojoba oil and orange oil may be harmful and are likely to…

Mumbai: India’s biotech flagship Biocon’s profitability is being pulled down by structured venture debt prompting it to look at a…

Generic drug companies in India are not expected to be affected by US President Donald Trump’s new order to bring…

New Delhi: Vaccines, antimicrobials, narcotic drugs and psychotropic substances, and additional cancer drugs would have to mandatorily print or affix…

New Delhi: RSS affiliate Laghu Udyog Bharati (LUB), which supports the small-scale industry, has urged the government to drop the…

Dr Stuti Khare Shukla, MD Dermatologist, fondly called as Hair Growth Queen of India & Celebrity Hair Specialist of Bollywood…

Mumbai: US President Donald Trump’s executive order to drugmakers to lower medicine prices in the US to levels other countries…

The US government’s order to pharma firms to lower the cost of prescription medicines within 30 days will not impact…

Mumbai: President Donald Trump’s sweeping plan to reduce prescription drug prices in the United States may impact Indian pharmaceutical companies,…

India has not accepted the demand of the UK for inclusion of a ‘data exclusivity’ provision in the free trade…

India’s pharma industry is likely to see a sharp increase in the number of surprise inspections by the US Food…

In less than two months after diabetes drug Empagliflozin went off patent, Indian branded generic players have crowded the market…

Pharma major Dr Reddy’s Laboratories Ltd is increasingly focussing on launching innovative products through partnerships with an aim to grow…

Biopharmaceutical firm Biocon plans to invest $150 million in capital expenditure over the next couple of years, with $100 million…

Zydus Lifesciences on Friday said it has received approval from the US health regulator to market a generic medication to…

Drug firm FDC Ltd is recalling over 60,000 bottles of a generic medication, used to treat glaucoma, in the US…

Only a small number of pharmaceutical companies have submitted plans for upgradation of facilities even as a revised deadline for…

The recent executive orders on pharma issued by President Donald Trump are expected to create significant challenges for Indian pharmaceutical…

Consumption of Mounjaro, Eli Lilly’s blockbuster weight-loss drug, more than tripled within a month of its launch in India, according…

Aster DM Healthcare on Wednesday said it will invest Rs 480 crore to set up a 430-bed multispecialty hospital in…

New Delhi: A day after ET broke the news that the government is giving final touches to a set of…

TPG has agreed to acquire a 35% stake in drug containment firm SCHOTT Poonawalla from Serum Institute of India (SII)….

The government is giving final touches to a revised set of regulations to set stringent quality standards for research and…

New Delhi: Biocon Ltd on Monday said its arm Biocon Biologics Ltd has secured multiple market access agreements in the…

Manipal Hospitals, Singapore’s IHH Healthcare, Blackstone-owned hospital chain Quality Care India, Max Healthcare, KKR & Co. and EQT Partners are…

India could receive the dengue vaccine as early as next year. According to a report by the Times of India,…

Zydus Lifesciences Ltd on Wednesday said it has received final approval from the US health regulator to manufacture the generic…

Mumbai: Inroads of blockbuster weight-loss medications such as Eli Lilly’s Mounjaro and Wegovy that Novo Nordisk is expected to bring…

New Delhi: The country’s top advisory body on drugs has proposed to constitute a sub-committee to decide if people can…

Alembic Pharmaceuticals on Friday said it has received approval from the US health regulator to market a generic medication for…

The government is considering bringing the controversial opioid Tapentadol under the Narcotic Drugs and Psychotropic Substances (NDPS) Act following allegations…

Leading healthcare service providers Aster DM Healthcare has completed acquisition of 5% stake in Quality Care India Ltd (QCIL) from…

New Delhi: Despite concerns over presence of cancer causing agents in popular antacid Ranitidine and a recent recommendation by an…

Drugmaker BDR Pharmaceuticals is looking to expand its US footprint through buyouts of manufacturing facilities with an investment of $100…

New Delhi: Private hospital chain Max Healthcare plans to invest Rs 6,000 crore over the next three years to expand…

Max Healthcare Institute Ltd will invest Rs 6,000 crore by 2028 to add 3,700 beds across key locations in India,…

Dr Reddy’s Laboratories on Monday said it has expanded its partnership with Sanofi Healthcare to introduce a novel drug for…

Global Health, which operates hospitals under the Medanta brand, on Monday said it plans to invest around Rs 500 crore…

New Delhi: Commerce and industry minister Piyush Goyal Sunday said that India “very often” gets requests to grant fresh patents…

India’s pharma and healthcare sector continue to see rising investor interest with an increasing shift in focus to scalable and…

The Delhi High Court on Thursday directed pharmaceutical companies to issue advisories to doctors, chemists, and retailers stating that fixed-dose…

Zydus Lifesciences on Saturday said the US health regulator has issued six observations after inspecting its Gujarat-based API manufacturing unit….

New Delhi: To ensure timely access to life saving orphan drugs, the government has exempted mandatory sampling and testing of…

SS Innovations International – the developers of indigenous surgical robotic technologies – said on Thursday that it has listed on…

In a rare acknowledgement of India’s strategic importance, Reckitt Benckiser Group Plc’s global chief executive officer Kris Licht said the…

In a relief to pharma companies, including Glenmark Pharmaceuticals and Zuventus Healthcare, the Delhi High Court on Thursday held that…

New Delhi: India’s top advisory board on drugs is considering a plan to rein in the sale of commonly used…

Aurobindo Pharma on Wednesday said its wholly- owned arm Eugia Pharma Specialities Ltd has received final approval from the USFDA…

India’s premier health research body has recommended a ban on popular painkiller and anti-fever medicine Nimesulide in patients below 18…

Dr Reddy’s Laboratories and Lupin are recalling products in the US market due to labelling and manufacturing errors, respectively, according…

An Indian pharma company is caught in the Russian-Ukraine conflict zone, prompting a pharma lobby group to seek Prime Minister…

Former Fortis Healthcare promoter Shivinder Mohan Singh has moved a plea before the National Company Law Tribunal for personal insolvency,…

New Delhi: Pharmacists have raised questions on the procedure to handle several medicines that were recently banned for use in…

Nearly 19 years after two Mumbai-based couples made medical history by donating kidneys to each other’s spouses, the central government…

Mumbai: Uncertainty over US tariffs and global macroeconomic headwinds have slowed down the hiring momentum at pharmaceutical and healthcare global…

New Delhi: Hectic discussions were held in the Union health ministry this week to weigh options to shield India’s pharmaceutical…

New Delhi | Mumbai: A new oral pill for weight loss has moved a step closer to commercial launch, raising…

Divi’s Laboratories on Friday said it has inked a supply agreement with a global pharmaceuticals firm. Under the long-term agreement,…

New Delhi: The government last week prohibited the use of certain cough syrup brands for those below four years of…

Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator to market a generic anticonvulsant medication….

New Delhi: India’s drug regulator has ordered companies to stop manufacture and sale of 35 fixed dose combinations (FDCs), saying…

The Central Drugs Standard Control Organisation (CDSCO), the apex regulatory authority for pharmaceuticals in India, has mandated that drug regulators…

New Delhi: Amid the sweltering heat, demand for dehydration-preventing drinks has soared in India. According to market research firm PharmaTrac,…

AstraZeneca Pharma India Ltd on Tuesday said it has surrendered the marketing authorisation of prostate cancer treatment drug Olaparib (Lynparza)…

Mumbai: Sanofi India has started the process of selling its flagship insulin brand, Lantus, with major domestic pharmaceutical companies such…

Hyderabad-based pharmaceutical major Dr Reddy’s Laboratories on Monday rejected a media report that claimed that the company is reducing its…

NEW DELHI: Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US…

India’s healthcare expenditure will surge from 3.3 per cent to 5 per cent of its GDP by 2030, said CareEdge…

Investors who have turned upbeat about India’s healthcare assets over the past one year are also examining the sec tor-comprising…

Habib Khorakiwala, Chairman of pharma company Wockhardt on Friday indicated that any imposition of tariffs on pharma products by the…

Indian drug makers such as Dr Reddy’s Laboratories, Zydus Lifesciences and MSN Labs are setting up new manufacturing capacities as…

Aurobindo Pharma Ltd on Friday said the US health regulator has issued a Form 483 with 11 observations to the…

India’s booming pharma deal market may hit a rough patch due to the prevailing uncertainty over potential US tariffs on…

Sun Pharmaceutical Industries Ltd on Thursday said a US court has ruled in its favour and vacated a preliminary injunction…

Mumbai: Drugmaker Natco Pharma has said it will price its rare disease drug Risdiplam used to treat spinal muscular atrophy…

Drug firms Glenmark and Biocon are recalling products in the US for manufacturing issues, according to the US health regulator….

President Donald Trump on Tuesday announced that the U.S. will soon introduce a “major” tariff on pharmaceutical imports. Speaking at…

The Union Health Ministry is planning to roll out capacity building activities for frontline workers involved in administration of Human…

MUMBAI: Bulge-bracket private equity funds are increasingly investing in single-speciality Indian hospital chains that present a robust growth potential in…

Sun Pharmaceutical Industries on Monday said it has introduced a medication for the treatment of Erosive Esophagitis of all grades….

Danish pharma giant Novo Nordisk is preparing to launch blockbuster anti-diabetes and weight-loss drug Wegovy (semaglutide) in India. To get…

Health insurance sector in India is facing a paradox. While premium collections have surged dramatically, insurers are grappling with a…

In a major blow to the medical devices sector, the US President Donald Trump imposed a steep 27% reciprocal tariff…

Kerala Health Minister Veena George on Saturday announced that digital payment systems have been introduced in government hospitals across the…

Mumbai: The relief at being spared from reciprocal tariffs did not last long for India’s drug makers, with US President…

Bengaluru-based People Tree Hospital secures ₹220 crore investment from BlackRock, the world’s largest asset management firm, to expand its capacity…

Large Indian drug makers, some of which get as much as half their revenue from the US market, were relieved…

The US administration has exempted pharmaceuticals from reciprocal tariffs, underscoring the critical role played by generic medicines globally, Indian Pharmaceutical…

Fortis Healthcare has purchased the Fortis trademark previously owned by the company’s erstwhile promoters, brothers Malvinder and Shivinder Singh, in…

Mumbai: Swiss pharma giant Novartis AG’s plans to sell a 70.68% equity stake in its listed arm Novartis India has…

New Delhi: Gennova Biopharmaceuticals, a subsidiary of Emcure Pharmaceuticals, on Tuesday announced a partnership with the Coalition for Epidemic Preparedness…

India’s exporters are bracing for President Donald Trump’s tariffs. Some are confident that whatever is announced on Wednesday will not…

India has developed its first indigenous MRI machine, set to be installed at AIIMS Delhi by October for trials. The…

Healthcare provider Ankura Hospitals on Monday said it has secured Rs 165 crore in funding from the Asian Development Bank…

Mumbai: Global investment firm KKR is in discussions with US fund Comvest Investment Partners, to acquire Leixir Dental Laboratory Group,…

The division bench of the Delhi High Court on Wednesday asked Natco Pharma to maintain status quo on the launch…

In today’s fast-evolving healthcare landscape, digital skills are no longer optional—they’re a key advantage. The demand for healthcare professionals extends…

The Central Drugs Laboratories in its monthly drug alert for February found 47 drug samples manufactured by various firms to…

Mumbai: Eli Lilly, the world’s most-valued drugmaker that seeks to shake up India’s lifestyle disease management through its recent introduction…

Kotak Alternate Asset Managers on Wednesday announced a Rs 1,050-crore investment in Tirupati Medicare, which will support the pharma company’s…

Prices of essential medicines, such as painkillers, antibiotics, anti-infectives, anti-diabetics and cancer drugs, will see a modest increase from April…

New Delhi: Deaths and soaring global HIV infections would be the direct result of US President Donald Trump’s decision to…

Homegrown Kedaara Capital and US-based TA Associates are among a clutch of private equity (PE) firms in talks to acquire…

Eli Lilly’s global CEO David Ricks is spearheading the worldwide launch of popular diabetes and anti-obesity drugs Mounjaro and Zepbound….

Mumbai | New Delhi: Pharma major Eli Lilly is open to partnerships with Indian companies to sell its blockbuster anti-diabetes…

Healthcare product company, Entero Healthcare Solutions, has announced the launch of its “HealthEdge” program to modernise retail pharmacies. Entero also…

The Delhi High Court on Monday rejected Swiss multinational F. Hoffmann-La Roche AG’s petition seeking to temporarily restrain Natco Pharma…

New Delhi: India is planning to develop left ventricular assist devices (LVADs), which help the heart pump blood, people familiar…

Health and Family Welfare Minister JP Nadda said the government is following a comprehensive health policy that includes use of…

It is an incredibly challenging time for global funding with the Global North focusing inwards but it’s also “a real…

Indian vaccine maker Bharat Biotech said on Thursday it had invested $75 million in its first cell and gene therapy…

MUMBAI: Bharat Biotech, India’s leading vaccine maker, is investing Rs 600 crore to expand into cell and gene therapies, the…

Mumbai: Diagnostics chain Metropolis Healthcare plans to acquire 2-3 companies every year over the next few years to expand its…

Guess what? There’s this shot you can get—Rs 14,000 a month—for weight loss. But, but, but… India’s obesity problem is…

New Delhi: US pharmaceutical major Eli Lilly on Thursday introduced its globally popular anti-diabetes and obesity drug Mounjaro (tirzepatide) in…

Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country’s drug regulator,…

New Delhi: The Association of Indian Medical Device Industry (AiMeD) has urged the government to impose safeguard duties on 12…

New Delhi: Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to…

Zydus Lifesciences Ltd on Tuesday said it has received final approval from the US health regulator to manufacture a generic…

New Delhi: The All India Institute of Medical Sciences (AIIMS) is reeling under an acute shortage of staff, with 430…

The government may offer easier market access for US medical device firms as part of its efforts to mitigate the…

An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in…

GV Prasad, co-chairman and managing director, Dr Reddy’s Laboratories says large mergers and acquisitions in the Indian pharmaceutical market are…

Prolonged use of steroid-based inhalers for respiratory issues like asthma and bronchitis, frequent application of nasal sprays for allergies, and…

The world looked on in awe as DeepSeek, a tiny artificial intelligence (AI) star tup in Hangzhou, overnight shook the…

Thiruvananthapuram, India became a vaccine superpower with Covaxin’s development and now produces 60 per cent of the world’s vaccines, said…

A parliamentary committee has expressed concern over posts of scientists in the Department of Health Research (DHR) lying vacant for…

Dr. Reddy’s Laboratories is recalling Lot No: A1540076 of Levetiracetam 0.75% Sodium Chloride Injection, 1,000 mg/100 mL, single-dose infusion bags…

The Parliamentary Standing Committee on Health and Family Welfare, in its latest report, has expressed concerns over the functioning of…

A study linking Indian-made generic drugs to a higher risk of serious side effects in the US has drawn backlash…

Global buyout funds Blackstone, Hillhouse Investment, TPG Capital, and General Atlantic have submitted non-binding bids to acquire AGS Health, valuing…

Several domestic drug companies today launched the blockbuster diabetes drug Empagliflozin with domestic drugmaker- Mankind pharma launching it at 90…

The charitable trust that runs Mumbai’s well-known Lilavati Hospital on Tuesday alleged that funds to the tune of over Rs…

India’s Syngene International on Monday said it has acquired its first biologics facility in the United States from Emergent Manufacturing…

Mumbai-based Aveo Pharmaceuticals said the company has been issued stop-production notice for non-compliance with manufacturing standards and not for export…

Zydus Lifesciences on Monday said it has received approval from US health regulator USFDA to market a generic antifungal medication…

The Pharmaceuticals Export Promotion Council (Pharmexcil) has sought a review of a new rule for drug exports that requires a…

The US health regulator has pulled up Granules India for failing to maintain buildings for drug storage and avoiding adequate…

Hyderabad-based Apollo Health & Lifestyle Limited (AHLL) has acquired a controlling stake in Lucknow-based Care Diagnostics for an undisclosed sum…

The country has witnessed an alarming surge in counterfeit medicines flooding retail markets, a spike of nearly 50 per cent…

New Delhi: Delhi Health Minister Pankaj Singh announced on Thursday that the registration process for the Ayushman Bharat scheme will…

Did you know that heart disease is a leading cause of around 17.9 million deaths worldwide per year?1 If you…

Mumbai: The Indian Pharmaceutical Alliance (IPA), which represents the country’s largest drug makers such as Cipla, Dr Reddy’s Laboratories and…

A private eye hospital in the city has announced a breakthrough in LASIK surgery, reducing treatment time to under 10…

All clinical research organisations in India will have to get registered with the country’s drug regulatory authority by April 1,…

Gujarat-based Senores Pharmaceuticals on Tuesday said it will acquire a basket of 14 Abbreviated New Drug Applications from Dr Reddy’s…

India is likely to get a list of drugs which will become over the counter (OTC) from a prescription drug,…

Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid. The company, with…

AstraZeneca Pharma India Ltd on Monday said it has received approval from drug regulator CDSCO to import and distribute cancer…

India’s largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes drug in…

Mumbai: A looming threat of reciprocal tariffs on exports of pharmaceuticals from India by US President Donald Trump initially caused…

Glenmark Pharmaceuticals is recalling close to 15 lakh bottles of a generic medication used in the treatment of attention deficit…

The healthcare and education systems are being plagued by commodification and commercialisation, said Vice President Jagdeep Dhankhar on Saturday, underscoring…

Union Health Minister JP Nadda on Saturday flagged off the Jan Aushadhi Raths to kick off the Jan Aushadhi Saptah…

Tariffs should not influence decisions at Indian drug companies, Cipla’s top executive said on Friday, as the industry braces for…

Did you know that obesity isn’t just about carrying extra weight? It can have serious effects, especially if you are…

New Delhi: The Department of Pharmaceuticals (DoP) has formed a technical committee to formulate the strategy and a roadmap for…

India’s contract drug makers have urged the government to remove regulatory hurdles and grant faster clearance to vital raw material…

Drugmaker Merck, known as MSD outside of the U.S. and Canada, expects to increase its workforce across its India sites…

India’s Contract Research Development and Manufacturing Organisation (CRDMO) sector is at an inflection point, with the potential to grow to…

Gland Pharma Ltd on Tuesday said the US health regulator has issued a Form 483 with three observations to its…

Perimenopause brings a lot of changes, and the wrong food choices can make things worse. Here’s what you should avoid.

Mumbai-based drugmaker Aveo Pharmaceuticals is facing a controversy over the export of addictive opioid drugs to West African nations such…

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further…

NEW DELHI/MUMBAI: The government on Sunday said the combination of tapentadol and carisoprodol drugs is not approved in India, and…

Indian pharma industry is capable of delivering 100 new drugs by 2047 for global markets backed by enhanced research and…

The Drug Controller General of India has ordered a ban on the production of tapentadol and carisoprodol, the two drugs…

Drug firm Granules India on Friday said it has acquired Switzerland-based CDMO firm Senn Chemicals AG for CHF 20 million…

Government authorities have conducted risk-based inspections at more than 500 pharmaceutical manufacturing units since 2022 and people in the know…

Diabetes has become a major health issue in India, with approximately 101 million people currently diagnosed and 136 million more…

Generic drugs made in India are related to 54 per cent more severe adverse events, including hospitalisation, disability and death,…

India’s Contract Research, Development, and Manufacturing Organization (CRDMO) industry is on a strong growth trajectory, with its market size expected…

New Delhi: US President Donald Trump’s plan to levy tariffs of about 25% on pharmaceuticals can potentially hurt Indian companies…

NEW DELHI: The National Pharmaceutical Pricing Authority (NPPA) has asked drug manufacturers and associated marketing companies to revise the maximum…

NEW DELHI: The Indian Pharmaceutical Association (IPA) has raised concerns regarding the recent diktat of the National Pharmaceutical Pricing Authority…